Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Mitochondrially targeted tamoxifen alleviates markers of obesity and type 2 diabetes mellitus in mice

E. Vacurova, J. Trnovska, P. Svoboda, V. Skop, V. Novosadova, DP. Reguera, S. Petrezselyová, B. Piavaux, B. Endaya, F. Spoutil, D. Zudova, J. Stursa, M. Melcova, Z. Bielcikova, L. Werner, J. Prochazka, R. Sedlacek, M. Huttl, SS. Hubackova, M....

. 2022 ; 13 (1) : 1866. [pub] 20220406

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22018847

Type 2 diabetes mellitus represents a major health problem with increasing prevalence worldwide. Limited efficacy of current therapies has prompted a search for novel therapeutic options. Here we show that treatment of pre-diabetic mice with mitochondrially targeted tamoxifen, a potential anti-cancer agent with senolytic activity, improves glucose tolerance and reduces body weight with most pronounced reduction of visceral adipose tissue due to reduced food intake, suppressed adipogenesis and elimination of senescent cells. Glucose-lowering effect of mitochondrially targeted tamoxifen is linked to improvement of type 2 diabetes mellitus-related hormones profile and is accompanied by reduced lipid accumulation in liver. Lower senescent cell burden in various tissues, as well as its inhibitory effect on pre-adipocyte differentiation, results in lower level of circulating inflammatory mediators that typically enhance metabolic dysfunction. Targeting senescence with mitochodrially targeted tamoxifen thus represents an approach to the treatment of type 2 diabetes mellitus and its related comorbidities, promising a complex impact on senescence-related pathologies in aging population of patients with type 2 diabetes mellitus with potential translation into the clinic.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018847
003      
CZ-PrNML
005      
20220804135134.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41467-022-29486-z $2 doi
035    __
$a (PubMed)35387987
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Vacurova, Eliska $u Institute of Biotechnology, Czech Academy of Sciences, Prague-West, Czech Republic $u Faculty of Science, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000271734189
245    10
$a Mitochondrially targeted tamoxifen alleviates markers of obesity and type 2 diabetes mellitus in mice / $c E. Vacurova, J. Trnovska, P. Svoboda, V. Skop, V. Novosadova, DP. Reguera, S. Petrezselyová, B. Piavaux, B. Endaya, F. Spoutil, D. Zudova, J. Stursa, M. Melcova, Z. Bielcikova, L. Werner, J. Prochazka, R. Sedlacek, M. Huttl, SS. Hubackova, M. Haluzik, J. Neuzil
520    9_
$a Type 2 diabetes mellitus represents a major health problem with increasing prevalence worldwide. Limited efficacy of current therapies has prompted a search for novel therapeutic options. Here we show that treatment of pre-diabetic mice with mitochondrially targeted tamoxifen, a potential anti-cancer agent with senolytic activity, improves glucose tolerance and reduces body weight with most pronounced reduction of visceral adipose tissue due to reduced food intake, suppressed adipogenesis and elimination of senescent cells. Glucose-lowering effect of mitochondrially targeted tamoxifen is linked to improvement of type 2 diabetes mellitus-related hormones profile and is accompanied by reduced lipid accumulation in liver. Lower senescent cell burden in various tissues, as well as its inhibitory effect on pre-adipocyte differentiation, results in lower level of circulating inflammatory mediators that typically enhance metabolic dysfunction. Targeting senescence with mitochodrially targeted tamoxifen thus represents an approach to the treatment of type 2 diabetes mellitus and its related comorbidities, promising a complex impact on senescence-related pathologies in aging population of patients with type 2 diabetes mellitus with potential translation into the clinic.
650    _2
$a senioři $7 D000368
650    _2
$a zvířata $7 D000818
650    12
$a experimentální diabetes mellitus $x komplikace $x farmakoterapie $7 D003921
650    12
$a diabetes mellitus 2. typu $x komplikace $x farmakoterapie $7 D003924
650    _2
$a glukosa $x metabolismus $7 D005947
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    _2
$a obezita $x komplikace $x farmakoterapie $x metabolismus $7 D009765
650    _2
$a tamoxifen $x farmakologie $x terapeutické užití $7 D013629
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Trnovska, Jaroslava $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Svoboda, Petr $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Prague, Czech Republic $1 https://orcid.org/0000000172974208 $7 jn20000710631
700    1_
$a Skop, Vojtech $u Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD, 20892, USA $1 https://orcid.org/0000000246854429
700    1_
$a Novosadova, Vendula $u Institute of Molecular Genetics, Czech Academy of Sciences, Prague-West, Czech Republic
700    1_
$a Reguera, David Pajuelo $u Institute of Molecular Genetics, Czech Academy of Sciences, Prague-West, Czech Republic $1 https://orcid.org/0000000277159402
700    1_
$a Petrezselyová, Silvia $u Institute of Molecular Genetics, Czech Academy of Sciences, Prague-West, Czech Republic $1 https://orcid.org/000000033054540X
700    1_
$a Piavaux, Benoit $u Institute of Molecular Genetics, Czech Academy of Sciences, Prague-West, Czech Republic
700    1_
$a Endaya, Berwini $u Institute of Biotechnology, Czech Academy of Sciences, Prague-West, Czech Republic
700    1_
$a Spoutil, Frantisek $u Institute of Molecular Genetics, Czech Academy of Sciences, Prague-West, Czech Republic
700    1_
$a Zudova, Dagmar $u Institute of Molecular Genetics, Czech Academy of Sciences, Prague-West, Czech Republic
700    1_
$a Stursa, Jan $u Institute of Biotechnology, Czech Academy of Sciences, Prague-West, Czech Republic
700    1_
$a Melcova, Magdalena $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Prague, Czech Republic $1 https://orcid.org/0000000200546113
700    1_
$a Bielcikova, Zuzana $u General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000184349848 $7 xx0225233
700    1_
$a Werner, Lukas $u Institute of Biotechnology, Czech Academy of Sciences, Prague-West, Czech Republic
700    1_
$a Prochazka, Jan $u Institute of Molecular Genetics, Czech Academy of Sciences, Prague-West, Czech Republic
700    1_
$a Sedlacek, Radislav $u Institute of Molecular Genetics, Czech Academy of Sciences, Prague-West, Czech Republic $1 https://orcid.org/000000023352392X $7 xx0140532
700    1_
$a Huttl, Martina $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Hubackova, Sona Stemberkova $u Institute of Biotechnology, Czech Academy of Sciences, Prague-West, Czech Republic. sona.stemberkova@ibt.cas.cz $1 https://orcid.org/0000000234546840
700    1_
$a Haluzik, Martin $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. halm@ikem.cz $1 https://orcid.org/0000000202016888 $7 xx0000707
700    1_
$a Neuzil, Jiri $u Institute of Biotechnology, Czech Academy of Sciences, Prague-West, Czech Republic. j.neuzil@griffith.edu.au $u School of Pharmacy and Medical Science, Griffith University, Southport, QLD, Australia. j.neuzil@griffith.edu.au $1 https://orcid.org/0000000224782460 $7 xx0115772
773    0_
$w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 13, č. 1 (2022), s. 1866
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35387987 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135128 $b ABA008
999    __
$a ok $b bmc $g 1822443 $s 1170090
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 13 $c 1 $d 1866 $e 20220406 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Možnosti archivace